|
|
Article: Millenia Hope Finalizes Processing Deal With Ropack; Canadian ISO 9002 Corporation to Process and Package MALAREX.
- Article from:
- Business Wire
- Article date:
- January 10, 2002
CopyrightCOPYRIGHT 2002 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health & Medical Writers
MONTREAL--(BUSINESS WIRE)--Jan. 10, 2002
Millenia Hope Inc. (OTCBB:MLHP), a Biotech Corporation, also listed for trading on the Berliner Wertpapier Borse (the Berlin Stock Exchange) (BWB:MLF) announced today that it is utilizing the services of Ropack, an FDA approved, HACCP and cGMP Compliant and ISO 9002 certified corporation for MALAREX(TM), Millenia's flagship antimalarial drug. Ropack will perform the following procedures at its plant in Montreal, Canada. Control the quality of the raw material received from our Brazilian manufacturing facility. Mix, encapsulate and package MALAREX(TM), conforming to U.S. ...